Immunology

Items 11-20 of 37

per page
Set Descending Direction
  1. DDX3 (human) (rec.) (active) (1000µg)
    BBL-2253
    BBL-2253-M0011 mg
    CHF 6'041.00
    DDX3 (human) (rec.) (active) (1000µg)
  2. DDX3 (human) (rec.) (active) (100µg)
    BBL-2252
    BBL-2252-C100100 µg
    CHF 1'809.00
    DDX3 (human) (rec.) (active) (100µg)
  3. DDX3 (human) (rec.) (active) (10µg)
    BBL-2251
    BBL-2251-C01010 µg
    CHF 600.00
    DDX3 (human) (rec.) (active) (10µg)
  4. EGFR, Soluble (human) (rec.)
    AG-40T-0041
    AG-40T-0041-C02525 µg
    CHF 620.00
  5. Fas (human):Fc (human) (rec.)
    AG-40B-0082
    AG-40B-0082-C05050 µg
    CHF 300.00
    AG-40B-0082-30503 x 50 µg
    CHF 600.00
  6. FasL (human) (multimeric) (rec.)
    AG-40B-0130
    AG-40B-0130-C01010 µg
    CHF 380.00
    AG-40B-0130-30103 x 10 µg
    CHF 760.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of FasL (human) (multimeric) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Prod. No.
  7. Fc (human):FasL, Soluble (human) (rec.)
    AG-40B-0132
    AG-40B-0132-C01010 µg
    CHF 335.00
    AG-40B-0132-30103 x 10 µg
    CHF 670.00
    Oligomerisation of FasL (h) efficiently triggers Jurkat cell death.Method: Jurkat cells were treated O/N with the indicated concentrations of MegaFasL, Soluble (human) (rec.) (Prod. No. AG-40B-0130), Fc:FasL, Soluble (human) (rec.) (Pr
  8. Fc (human):Grancalcin (human) (rec.)
    AG-40B-0242
    AG-40B-0242-C05050 µg
    CHF 440.00
  9. Fn14 (human):Fc (human) (rec.)
    AG-40B-0034
    AG-40B-0034-C05050 µg
    CHF 300.00
    AG-40B-0034-30503 x 50 µg
    CHF 600.00
  10. IL-2 (C145S Mutant) (human) (rec.) (His)
    CHI-HF-20102
    CHI-HF-20102-C01010 µg
    CHF 210.00

Items 11-20 of 37

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.